Efficacy and safety of bisoprolol fumarate compared with carvedilol in Japanese patients with chronic heart failure: results of the randomized, ... View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2014-03

AUTHORS

Masatsugu Hori, Ryozo Nagai, Tohru Izumi, Masunori Matsuzaki

ABSTRACT

Bisoprolol fumarate (bisoprolol) is a β-blocker widely used to treat chronic heart failure (CHF). However, few studies have compared its efficacy and safety with those of the widely used β-blocker carvedilol in Japanese patients with CHF. We designed a confirmatory trial of bisoprolol using carvedilol as a control drug; however, the trial was discontinued after an off-label use of bisoprolol was approved during the study. Bisoprolol and carvedilol were administered for 32 weeks in 31 and 28 patients, respectively. The mean maintenance doses of bisoprolol and carvedilol were 3.3 and 13.6 mg/day, respectively, and the mean durations of treatment were 188.2 and 172.9 days, respectively. Heart-rate changes were similar in both groups. The mean changes from baseline to Week 32 in left ventricular (LV) ejection fraction (EF) (bisoprolol vs carvedilol groups; 11.7 % ± 8.6 % vs 10.1 % ± 10.5 %), LV end-diastolic volume (-37.5 ± 48.7 vs -24.7 ± 29.4 ml), and LV end-systolic volume (-41.9 ± 43.0 vs -29.3 ± 25.9 ml) revealed a decrease in LV volume and an increase in LVEF in both groups. The cumulative event-free rate for a composite of cardiovascular death or admissions to hospital for worsening of CHF was 92.4 % and 94.7 % in the bisoprolol and carvedilol groups, respectively. Overall, 90.3 % and 85.7 % of patients were titrated up to the maintenance doses of bisoprolol and carvedilol, respectively. Bisoprolol, at half the dose used in other countries, is well tolerated and is as effective as carvedilol for treating Japanese patients with mild to moderate CHF. More... »

PAGES

238-247

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00380-013-0340-3

DOI

http://dx.doi.org/10.1007/s00380-013-0340-3

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1008794029

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/23559359


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adrenergic beta-Antagonists", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bisoprolol", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carbazoles", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chronic Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease-Free Survival", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Double-Blind Method", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Administration Schedule", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Early Termination of Clinical Trials", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Heart Failure", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Heart Rate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Japan", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Patient Admission", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Propanolamines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Severity of Illness Index", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Stroke Volume", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Time Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Outcome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ventricular Function, Left", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ventricular Remodeling", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Osaka Medical Center for Cancer and Cardiovascular Diseases", 
          "id": "https://www.grid.ac/institutes/grid.416963.f", 
          "name": [
            "Osaka Medical Center for Cancer and Cardiovascular Diseases, 1-3-3 Nakamichi, Higashinari-ku, 537-8511, Osaka, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hori", 
        "givenName": "Masatsugu", 
        "id": "sg:person.01324324532.27", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01324324532.27"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of Tokyo", 
          "id": "https://www.grid.ac/institutes/grid.26999.3d", 
          "name": [
            "Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, 113-8655, Tokyo, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nagai", 
        "givenName": "Ryozo", 
        "id": "sg:person.0772176333.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0772176333.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Kitasato University", 
          "id": "https://www.grid.ac/institutes/grid.410786.c", 
          "name": [
            "Department of Cardio-Angiology, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, 252-0374, Sagamihara, Kanagawa, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Izumi", 
        "givenName": "Tohru", 
        "id": "sg:person.0672551771.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0672551771.07"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Yamaguchi University", 
          "id": "https://www.grid.ac/institutes/grid.268397.1", 
          "name": [
            "Department of Medicine and Clinical Science, Division of Cardiology, Yamaguchi University Graduate School of Medicine, 1-1-1 Minamikogushi, 755-8505, Ube, Yamaguchi, Japan"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Matsuzaki", 
        "givenName": "Masunori", 
        "id": "sg:person.01036165064.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036165064.24"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/s0894-7317(89)80013-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000017375"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm200105313442201", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004626599"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jacc.2010.05.011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004716884"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0894-7317(89)80014-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005180661"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.cir.103.10.1428", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007326373"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(98)11181-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007565381"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm199605233342101", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007851848"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa020233", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010471027"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.amjcard.2005.05.037", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021249709"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(99)04440-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022416020"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/eurjhf/hfr020", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026231022"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.cir.0000016642.15031.34", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026794786"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/eurheartj/ehn309", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031387979"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/eurheartj/ehi386", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034003794"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1054/j.cardfail.2003.09.001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037220842"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1054/j.cardfail.2003.09.001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037220842"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/circulationaha.109.192065", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041766066"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.amjcard.2005.04.049", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043205222"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ahj.2003.07.023", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053542140"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.7326/0003-4819-134-7-200104030-00008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1073704755"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.7326/0003-4819-150-11-200906020-00006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1073710478"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2014-03", 
    "datePublishedReg": "2014-03-01", 
    "description": "Bisoprolol fumarate (bisoprolol) is a \u03b2-blocker widely used to treat chronic heart failure (CHF). However, few studies have compared its efficacy and safety with those of the widely used \u03b2-blocker carvedilol in Japanese patients with CHF. We designed a confirmatory trial of bisoprolol using carvedilol as a control drug; however, the trial was discontinued after an off-label use of bisoprolol was approved during the study. Bisoprolol and carvedilol were administered for 32 weeks in 31 and 28 patients, respectively. The mean maintenance doses of bisoprolol and carvedilol were 3.3 and 13.6 mg/day, respectively, and the mean durations of treatment were 188.2 and 172.9 days, respectively. Heart-rate changes were similar in both groups. The mean changes from baseline to Week 32 in left ventricular (LV) ejection fraction (EF) (bisoprolol vs carvedilol groups; 11.7 % \u00b1 8.6 % vs 10.1 % \u00b1 10.5 %), LV end-diastolic volume (-37.5 \u00b1 48.7 vs -24.7 \u00b1 29.4 ml), and LV end-systolic volume (-41.9 \u00b1 43.0 vs -29.3 \u00b1 25.9 ml) revealed a decrease in LV volume and an increase in LVEF in both groups. The cumulative event-free rate for a composite of cardiovascular death or admissions to hospital for worsening of CHF was 92.4 % and 94.7 % in the bisoprolol and carvedilol groups, respectively. Overall, 90.3 % and 85.7 % of patients were titrated up to the maintenance doses of bisoprolol and carvedilol, respectively. Bisoprolol, at half the dose used in other countries, is well tolerated and is as effective as carvedilol for treating Japanese patients with mild to moderate CHF. ", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00380-013-0340-3", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1095887", 
        "issn": [
          "0910-8327", 
          "1615-2573"
        ], 
        "name": "Heart and Vessels", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "29"
      }
    ], 
    "name": "Efficacy and safety of bisoprolol fumarate compared with carvedilol in Japanese patients with chronic heart failure: results of the randomized, controlled, double-blind, Multistep Administration of bisoprolol IN Chronic Heart Failure II (MAIN-CHF II) study", 
    "pagination": "238-247", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "29e5f47f41552a77682b8031296234ba9c9b3c5bcdba8243fd3c15e6a10b715b"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "23559359"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8511258"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00380-013-0340-3"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1008794029"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00380-013-0340-3", 
      "https://app.dimensions.ai/details/publication/pub.1008794029"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T15:43", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8664_00000480.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007/s00380-013-0340-3"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00380-013-0340-3'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00380-013-0340-3'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00380-013-0340-3'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00380-013-0340-3'


 

This table displays all metadata directly associated to this object as RDF triples.

259 TRIPLES      21 PREDICATES      74 URIs      46 LITERALS      34 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00380-013-0340-3 schema:about N026bbd8db5cb4cdda9a2b760354b9b44
2 N074c1d553aad41eda3d908b9e9a163ff
3 N1278f5811ed74a76baebc934a1dc04f2
4 N129ed58e907042468506d1d731029f7a
5 N19d1cd8ad26143e7932afcda00ca6f3c
6 N3188bf1e9a4348d59769f72f1818a161
7 N33f475616ca048e8a17ab2f28ffeca0f
8 N40970e6557f349a0801372ab63268d3b
9 N463689f41bf64fb8b9ff980323e24115
10 N64e4a1263f3846ad958f2934ba79c47c
11 N67156d78fd7c4e6f8ff6b2c34ccb9bb5
12 N7309ff605e01446a94fd1c8b6f529f6f
13 N8712cf45b25f47c495529a2fccda91c9
14 Naf481f8badca4f80850c6fca9e3c46ba
15 Nb35128dce88c467aa64abe51fc813284
16 Nc6d4ce75579d40ae99f0e99088202455
17 Nd458b1b0da3f44c6bde1821d217425f0
18 Nd68b2a548b7f47528945bd18f9e55d37
19 Nd99e855dc8454d07a0748ec27b7480ea
20 Ne0e5ada233cd4798ae547553384555c2
21 Ne1bc9e67e84e47d88465f9fedf32c8ac
22 Ne3df6c504e4d4b968952f74988dabc90
23 Ne4aef1762cc740e2aaf4b280e6d0dec7
24 Nebccc4f259c64386875dca87268f4cf1
25 Nef3d6bfab2e54e56b135141352505ad2
26 anzsrc-for:11
27 anzsrc-for:1102
28 schema:author N707bbe601cd74e23b39a9dce0d6096b0
29 schema:citation https://doi.org/10.1016/j.ahj.2003.07.023
30 https://doi.org/10.1016/j.amjcard.2005.04.049
31 https://doi.org/10.1016/j.amjcard.2005.05.037
32 https://doi.org/10.1016/j.jacc.2010.05.011
33 https://doi.org/10.1016/s0140-6736(98)11181-9
34 https://doi.org/10.1016/s0140-6736(99)04440-2
35 https://doi.org/10.1016/s0894-7317(89)80013-6
36 https://doi.org/10.1016/s0894-7317(89)80014-8
37 https://doi.org/10.1054/j.cardfail.2003.09.001
38 https://doi.org/10.1056/nejm199605233342101
39 https://doi.org/10.1056/nejm200105313442201
40 https://doi.org/10.1056/nejmoa020233
41 https://doi.org/10.1093/eurheartj/ehi386
42 https://doi.org/10.1093/eurheartj/ehn309
43 https://doi.org/10.1093/eurjhf/hfr020
44 https://doi.org/10.1161/01.cir.0000016642.15031.34
45 https://doi.org/10.1161/01.cir.103.10.1428
46 https://doi.org/10.1161/circulationaha.109.192065
47 https://doi.org/10.7326/0003-4819-134-7-200104030-00008
48 https://doi.org/10.7326/0003-4819-150-11-200906020-00006
49 schema:datePublished 2014-03
50 schema:datePublishedReg 2014-03-01
51 schema:description Bisoprolol fumarate (bisoprolol) is a β-blocker widely used to treat chronic heart failure (CHF). However, few studies have compared its efficacy and safety with those of the widely used β-blocker carvedilol in Japanese patients with CHF. We designed a confirmatory trial of bisoprolol using carvedilol as a control drug; however, the trial was discontinued after an off-label use of bisoprolol was approved during the study. Bisoprolol and carvedilol were administered for 32 weeks in 31 and 28 patients, respectively. The mean maintenance doses of bisoprolol and carvedilol were 3.3 and 13.6 mg/day, respectively, and the mean durations of treatment were 188.2 and 172.9 days, respectively. Heart-rate changes were similar in both groups. The mean changes from baseline to Week 32 in left ventricular (LV) ejection fraction (EF) (bisoprolol vs carvedilol groups; 11.7 % ± 8.6 % vs 10.1 % ± 10.5 %), LV end-diastolic volume (-37.5 ± 48.7 vs -24.7 ± 29.4 ml), and LV end-systolic volume (-41.9 ± 43.0 vs -29.3 ± 25.9 ml) revealed a decrease in LV volume and an increase in LVEF in both groups. The cumulative event-free rate for a composite of cardiovascular death or admissions to hospital for worsening of CHF was 92.4 % and 94.7 % in the bisoprolol and carvedilol groups, respectively. Overall, 90.3 % and 85.7 % of patients were titrated up to the maintenance doses of bisoprolol and carvedilol, respectively. Bisoprolol, at half the dose used in other countries, is well tolerated and is as effective as carvedilol for treating Japanese patients with mild to moderate CHF.
52 schema:genre research_article
53 schema:inLanguage en
54 schema:isAccessibleForFree false
55 schema:isPartOf N079d95f36a2344998b540ab9e16da2b0
56 N737fef7e89ad4c82b4720ec95faed999
57 sg:journal.1095887
58 schema:name Efficacy and safety of bisoprolol fumarate compared with carvedilol in Japanese patients with chronic heart failure: results of the randomized, controlled, double-blind, Multistep Administration of bisoprolol IN Chronic Heart Failure II (MAIN-CHF II) study
59 schema:pagination 238-247
60 schema:productId N0c090f585c0a417db674748e86cd2e67
61 N745d615e022747d4b19cfbd892a3698b
62 N88fba810f8c3448da9d42c53dac5a546
63 Ne911a86934ee4bc7a5908cda974b44c5
64 Nf108ca8070d24115ba56569a0a5fba97
65 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008794029
66 https://doi.org/10.1007/s00380-013-0340-3
67 schema:sdDatePublished 2019-04-10T15:43
68 schema:sdLicense https://scigraph.springernature.com/explorer/license/
69 schema:sdPublisher Ndf3c1e921a644aeea1a8b2a5014f5b85
70 schema:url http://link.springer.com/10.1007/s00380-013-0340-3
71 sgo:license sg:explorer/license/
72 sgo:sdDataset articles
73 rdf:type schema:ScholarlyArticle
74 N026bbd8db5cb4cdda9a2b760354b9b44 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
75 schema:name Aged
76 rdf:type schema:DefinedTerm
77 N058bb43b744b449289409dffd6bc8455 rdf:first sg:person.01036165064.24
78 rdf:rest rdf:nil
79 N074c1d553aad41eda3d908b9e9a163ff schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
80 schema:name Chronic Disease
81 rdf:type schema:DefinedTerm
82 N079d95f36a2344998b540ab9e16da2b0 schema:volumeNumber 29
83 rdf:type schema:PublicationVolume
84 N0c090f585c0a417db674748e86cd2e67 schema:name pubmed_id
85 schema:value 23559359
86 rdf:type schema:PropertyValue
87 N1278f5811ed74a76baebc934a1dc04f2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
88 schema:name Ventricular Function, Left
89 rdf:type schema:DefinedTerm
90 N129ed58e907042468506d1d731029f7a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
91 schema:name Stroke Volume
92 rdf:type schema:DefinedTerm
93 N19d1cd8ad26143e7932afcda00ca6f3c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
94 schema:name Treatment Outcome
95 rdf:type schema:DefinedTerm
96 N3188bf1e9a4348d59769f72f1818a161 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
97 schema:name Severity of Illness Index
98 rdf:type schema:DefinedTerm
99 N33f475616ca048e8a17ab2f28ffeca0f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
100 schema:name Humans
101 rdf:type schema:DefinedTerm
102 N40970e6557f349a0801372ab63268d3b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Propanolamines
104 rdf:type schema:DefinedTerm
105 N463689f41bf64fb8b9ff980323e24115 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Double-Blind Method
107 rdf:type schema:DefinedTerm
108 N4de25c892c714ea69a56cda4e0c8bae8 rdf:first sg:person.0772176333.38
109 rdf:rest Nb9cd7acc4cdd4c0ebd3e54ddcae7d273
110 N64e4a1263f3846ad958f2934ba79c47c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Early Termination of Clinical Trials
112 rdf:type schema:DefinedTerm
113 N67156d78fd7c4e6f8ff6b2c34ccb9bb5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Female
115 rdf:type schema:DefinedTerm
116 N707bbe601cd74e23b39a9dce0d6096b0 rdf:first sg:person.01324324532.27
117 rdf:rest N4de25c892c714ea69a56cda4e0c8bae8
118 N7309ff605e01446a94fd1c8b6f529f6f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Adrenergic beta-Antagonists
120 rdf:type schema:DefinedTerm
121 N737fef7e89ad4c82b4720ec95faed999 schema:issueNumber 2
122 rdf:type schema:PublicationIssue
123 N745d615e022747d4b19cfbd892a3698b schema:name readcube_id
124 schema:value 29e5f47f41552a77682b8031296234ba9c9b3c5bcdba8243fd3c15e6a10b715b
125 rdf:type schema:PropertyValue
126 N8712cf45b25f47c495529a2fccda91c9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Bisoprolol
128 rdf:type schema:DefinedTerm
129 N88fba810f8c3448da9d42c53dac5a546 schema:name doi
130 schema:value 10.1007/s00380-013-0340-3
131 rdf:type schema:PropertyValue
132 Naf481f8badca4f80850c6fca9e3c46ba schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Time Factors
134 rdf:type schema:DefinedTerm
135 Nb35128dce88c467aa64abe51fc813284 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Disease-Free Survival
137 rdf:type schema:DefinedTerm
138 Nb9cd7acc4cdd4c0ebd3e54ddcae7d273 rdf:first sg:person.0672551771.07
139 rdf:rest N058bb43b744b449289409dffd6bc8455
140 Nc6d4ce75579d40ae99f0e99088202455 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Male
142 rdf:type schema:DefinedTerm
143 Nd458b1b0da3f44c6bde1821d217425f0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Japan
145 rdf:type schema:DefinedTerm
146 Nd68b2a548b7f47528945bd18f9e55d37 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Ventricular Remodeling
148 rdf:type schema:DefinedTerm
149 Nd99e855dc8454d07a0748ec27b7480ea schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Prospective Studies
151 rdf:type schema:DefinedTerm
152 Ndf3c1e921a644aeea1a8b2a5014f5b85 schema:name Springer Nature - SN SciGraph project
153 rdf:type schema:Organization
154 Ne0e5ada233cd4798ae547553384555c2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Drug Administration Schedule
156 rdf:type schema:DefinedTerm
157 Ne1bc9e67e84e47d88465f9fedf32c8ac schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Carbazoles
159 rdf:type schema:DefinedTerm
160 Ne3df6c504e4d4b968952f74988dabc90 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Middle Aged
162 rdf:type schema:DefinedTerm
163 Ne4aef1762cc740e2aaf4b280e6d0dec7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
164 schema:name Heart Failure
165 rdf:type schema:DefinedTerm
166 Ne911a86934ee4bc7a5908cda974b44c5 schema:name nlm_unique_id
167 schema:value 8511258
168 rdf:type schema:PropertyValue
169 Nebccc4f259c64386875dca87268f4cf1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Heart Rate
171 rdf:type schema:DefinedTerm
172 Nef3d6bfab2e54e56b135141352505ad2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name Patient Admission
174 rdf:type schema:DefinedTerm
175 Nf108ca8070d24115ba56569a0a5fba97 schema:name dimensions_id
176 schema:value pub.1008794029
177 rdf:type schema:PropertyValue
178 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
179 schema:name Medical and Health Sciences
180 rdf:type schema:DefinedTerm
181 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
182 schema:name Cardiorespiratory Medicine and Haematology
183 rdf:type schema:DefinedTerm
184 sg:journal.1095887 schema:issn 0910-8327
185 1615-2573
186 schema:name Heart and Vessels
187 rdf:type schema:Periodical
188 sg:person.01036165064.24 schema:affiliation https://www.grid.ac/institutes/grid.268397.1
189 schema:familyName Matsuzaki
190 schema:givenName Masunori
191 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036165064.24
192 rdf:type schema:Person
193 sg:person.01324324532.27 schema:affiliation https://www.grid.ac/institutes/grid.416963.f
194 schema:familyName Hori
195 schema:givenName Masatsugu
196 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01324324532.27
197 rdf:type schema:Person
198 sg:person.0672551771.07 schema:affiliation https://www.grid.ac/institutes/grid.410786.c
199 schema:familyName Izumi
200 schema:givenName Tohru
201 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0672551771.07
202 rdf:type schema:Person
203 sg:person.0772176333.38 schema:affiliation https://www.grid.ac/institutes/grid.26999.3d
204 schema:familyName Nagai
205 schema:givenName Ryozo
206 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0772176333.38
207 rdf:type schema:Person
208 https://doi.org/10.1016/j.ahj.2003.07.023 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053542140
209 rdf:type schema:CreativeWork
210 https://doi.org/10.1016/j.amjcard.2005.04.049 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043205222
211 rdf:type schema:CreativeWork
212 https://doi.org/10.1016/j.amjcard.2005.05.037 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021249709
213 rdf:type schema:CreativeWork
214 https://doi.org/10.1016/j.jacc.2010.05.011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004716884
215 rdf:type schema:CreativeWork
216 https://doi.org/10.1016/s0140-6736(98)11181-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007565381
217 rdf:type schema:CreativeWork
218 https://doi.org/10.1016/s0140-6736(99)04440-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022416020
219 rdf:type schema:CreativeWork
220 https://doi.org/10.1016/s0894-7317(89)80013-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000017375
221 rdf:type schema:CreativeWork
222 https://doi.org/10.1016/s0894-7317(89)80014-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005180661
223 rdf:type schema:CreativeWork
224 https://doi.org/10.1054/j.cardfail.2003.09.001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037220842
225 rdf:type schema:CreativeWork
226 https://doi.org/10.1056/nejm199605233342101 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007851848
227 rdf:type schema:CreativeWork
228 https://doi.org/10.1056/nejm200105313442201 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004626599
229 rdf:type schema:CreativeWork
230 https://doi.org/10.1056/nejmoa020233 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010471027
231 rdf:type schema:CreativeWork
232 https://doi.org/10.1093/eurheartj/ehi386 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034003794
233 rdf:type schema:CreativeWork
234 https://doi.org/10.1093/eurheartj/ehn309 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031387979
235 rdf:type schema:CreativeWork
236 https://doi.org/10.1093/eurjhf/hfr020 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026231022
237 rdf:type schema:CreativeWork
238 https://doi.org/10.1161/01.cir.0000016642.15031.34 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026794786
239 rdf:type schema:CreativeWork
240 https://doi.org/10.1161/01.cir.103.10.1428 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007326373
241 rdf:type schema:CreativeWork
242 https://doi.org/10.1161/circulationaha.109.192065 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041766066
243 rdf:type schema:CreativeWork
244 https://doi.org/10.7326/0003-4819-134-7-200104030-00008 schema:sameAs https://app.dimensions.ai/details/publication/pub.1073704755
245 rdf:type schema:CreativeWork
246 https://doi.org/10.7326/0003-4819-150-11-200906020-00006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1073710478
247 rdf:type schema:CreativeWork
248 https://www.grid.ac/institutes/grid.268397.1 schema:alternateName Yamaguchi University
249 schema:name Department of Medicine and Clinical Science, Division of Cardiology, Yamaguchi University Graduate School of Medicine, 1-1-1 Minamikogushi, 755-8505, Ube, Yamaguchi, Japan
250 rdf:type schema:Organization
251 https://www.grid.ac/institutes/grid.26999.3d schema:alternateName University of Tokyo
252 schema:name Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, 113-8655, Tokyo, Japan
253 rdf:type schema:Organization
254 https://www.grid.ac/institutes/grid.410786.c schema:alternateName Kitasato University
255 schema:name Department of Cardio-Angiology, Kitasato University School of Medicine, 1-15-1 Kitasato, Minami-ku, 252-0374, Sagamihara, Kanagawa, Japan
256 rdf:type schema:Organization
257 https://www.grid.ac/institutes/grid.416963.f schema:alternateName Osaka Medical Center for Cancer and Cardiovascular Diseases
258 schema:name Osaka Medical Center for Cancer and Cardiovascular Diseases, 1-3-3 Nakamichi, Higashinari-ku, 537-8511, Osaka, Japan
259 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...